Intelligent Bio Solutions Inc (INBS)
2.72
+0.27
(+11.02%)
USD |
NASDAQ |
May 07, 12:52
Intelligent Bio Solutions Research and Development Expense (Quarterly): 0.3485M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3485M |
| September 30, 2023 | 0.1039M |
| June 30, 2023 | 0.1271M |
| March 31, 2023 | 0.2999M |
| December 31, 2022 | 0.0012M |
| September 30, 2022 | 0.0793M |
| June 30, 2022 | 0.6926M |
| March 31, 2022 | 0.4133M |
| December 31, 2021 | 2.641M |
| September 30, 2021 | 0.1068M |
| June 30, 2021 | 1.307M |
| March 31, 2021 | 2.156M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.3418M |
| September 30, 2020 | 0.0309M |
| June 30, 2020 | 0.0472M |
| March 31, 2020 | -0.0588M |
| December 31, 2019 | 0.4947M |
| September 30, 2019 | 0.1052M |
| June 30, 2019 | 2.211M |
| March 31, 2019 | 0.4313M |
| September 30, 2018 | 0.9873M |
| June 30, 2018 | 0.9825M |
| March 31, 2018 | 0.7086M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
-0.0588M
Minimum
Mar 2020
2.641M
Maximum
Dec 2021
0.6026M
Average
0.2999M
Median
Mar 2023
Research and Development Expense (Quarterly) Benchmarks
| Ainos Inc | 2.237M |
| OpGen Inc | 1.202M |
| Zomedica Corp | 3.099M |
| LENSAR Inc | 1.463M |
| Eargo Inc (DELISTED) | 4.742M |